Halorinna Sun-screen Travel Spf50 Lotion
NDC Package 84753-040-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Halorinna Sun-screen Travel Spf50 (sun screen) lotions is usesHelps prevent sunburnIf used as directed with other sun protectionmeasures (see Directions), decreases the riskof skin cancer and early aging causedby the sun. This formulation utilizes a lotion delivery system. Marketed by Guangdong Bisutang Biotechnology Co., Ltd, this product is identified by NDC 84753-040 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
84753-040-01
Package Description
50 mL in 1 BOTTLE
Product Code
84753-040
11-Digit Billing Format
84753004001

Clinical Specifications

Proprietary Name
Halorinna Sun-screen Travel Spf50
Non-Proprietary Name
Sun Screen
Substance Name
Butyl Methoxydibenzoylmethane; Ci 77891; Ethylhexyl Methoxycinnamate; Octocrylene; Phenylbenzimidazole Sulfonic Acid
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
UsesHelps prevent sunburnIf used as directed with other sun protectionmeasures (see Directions), decreases the riskof skin cancer and early aging causedby the sun.

Regulatory & Marketing

Labeler Name
Guangdong Bisutang Biotechnology Co., Ltd
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-23-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84753-040-01 identifies a specific commercial package of 50 ml in 1 bottle of Halorinna Sun-screen Travel Spf50, a human over the counter drug labeled by Guangdong Bisutang Biotechnology Co., Ltd. This lotion is formulated for topical use and contains butyl methoxydibenzoylmethane; ci 77891; ethylhexyl methoxycinnamate; octocrylene; phenylbenzimidazole sulfonic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangdong Bisutang Biotechnology Co., Ltd on March 23, 2026. The current certification is valid through December 31, 2027.

How is this Guangdong Bisutang Biotechnology Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84753004001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84753-040-01
11-Digit CMS (5-4-2)
84753-0040-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.